Skip to main content

Peer Review reports

From: Different mutational characteristics of the subsets of EGFR-tyrosine kinase inhibitor sensitizing mutation-positive lung adenocarcinoma

Original Submission
28 May 2018 Submitted Original manuscript
26 Oct 2018 Author responded Author comments - Eun Young Kim
9 Sep 2018 Reviewed Reviewer Report - Yihua Sun
24 Sep 2018 Reviewed Reviewer Report - Reviewer 2
Resubmission - Version 2
26 Oct 2018 Submitted Manuscript version 2
20 Nov 2018 Author responded Author comments - Eun Young Kim
10 Nov 2018 Reviewed Reviewer Report - Yihua Sun
15 Nov 2018 Reviewed Reviewer Report - Reviewer 2
Resubmission - Version 3
20 Nov 2018 Submitted Manuscript version 3
Publishing
20 Nov 2018 Editorially accepted
6 Dec 2018 Article published 10.1186/s12885-018-5116-9

You can find further information about peer review here.

Back to article page
\